|Dr. John McGraw M.Sc., Ph.D.||Pres, CEO, Member of Advisory Board & Director||17.68k||N/A||N/A|
|Ms. Jody Bellefleur CPA, CGA, CPA||Chief Financial Officer||6.91k||N/A||N/A|
|Ms. Jaclyn Thast||Operations Mang. & Corp. Sec.||76.01k||N/A||N/A|
|Mr. Ali Reza Sodagar||Legal Advisor & Independent Director||18.39k||N/A||N/A|
|Mr. Robert Louis Thast||Director & Special Advisor||103.65k||N/A||1954|
|Dr. Younes Achkire Ph.D.||Exec. VP of Product Engineering||N/A||N/A||N/A|
|Dr. Andrew M. Hernandez||Head of Imaging Technology||N/A||N/A||N/A|
Izotropic Corporation, a research and development company, commercializes diagnostic products for breast cancer. It develops and commercializes breast CT Imaging system; and next generation 3D breast CT imaging technology for the earlier detection, diagnosis, and treatment of breast cancer. The company was incorporated in 2016 and is headquartered in Surrey, Canada.
Izotropic Corporation’s ISS Governance QualityScore as of N/A is N/A. The pillar scores are Audit: N/A; Board: N/A; Shareholder Rights: N/A; Compensation: N/A.